Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

12,664 public trials 2,917 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 582 locations
View Trial Details
Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

NCT05099003

Conditions
Glioma, Malignant Glioma, Neoplasms, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 127 locations
View Trial Details
Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT06890338

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
  • University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
View all 67 locations
View Trial Details
Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

NCT06064097

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 85 locations
View Trial Details
Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT06172296

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 178 locations
View Trial Details
Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

NCT05902169

Conditions
Astrocytoma, GBM, Glioblastoma, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • UCHealth Aurora, Colorado, United States
  • Mayo Clinic of Jacksonville Florida Jacksonville, Florida, United States
View all 51 locations
View Trial Details

Related conditions